New hope for brain cancer: drug cocktail plus keto diet shows promise
NCT ID NCT05183204
First seen Jan 05, 2026 · Last updated May 22, 2026 · Updated 19 times
Summary
This study tests a new treatment for glioblastoma, an aggressive brain cancer. Patients take two drugs (paxalisib and metformin) and follow a high-fat, low-carbohydrate (ketogenic) diet. The goal is to see if this combination is safe and can slow tumor growth. The trial includes both newly diagnosed and recurrent cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Weill Cornell Medicine
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.